Status:
UNKNOWN
The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia
Lead Sponsor:
Mansoura University
Conditions:
Pneumonia
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.
Eligibility Criteria
Inclusion
- Age \>18 years.
- Fever ≥ 38º C with upper respiratory tract manifestations, generalized bone ache with or without gastrointestinal symptoms as diarrhea.
- Chest CT with signs suggestive of COVID-19.
- Mild and moderate cases of COVID-19 pneumonia with respiratory and hemodynamic stability. - High C reactive protein (CRP).- With or without history of contact with index case who is isolated in a governmental hospital assigned for treatment of patients proved to have RT-PCR positive test for COVID-19
- With or without abnormalities in the total or differential white cell count.
- Welling to sign a fully informed consent.
Exclusion
- Severe and critical illness with respiratory failure and/ or hemodynamic instability.
- CT with pleural effusion with or without lung cavitation.
- Other organ failure.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04374591
Start Date
August 1 2020
End Date
November 1 2020
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gomhoria Street
Al Mansurah, Outside U.S./Canada, Egypt, 35516